DLX4 and breast carcinoma: ChIP-on-chip (Chromatin Immunoprecipitation on microarray promoter chip) combined with expression microarray studies have demonstrated that BP1 may regulate VEGF expression in Hs578T breast cancer cells as well [42]; (vii) epithelial to mesenchymal transition [43].